• black-back-closed-envelope-shape
  • White Instagram Icon
  • White Facebook Icon
  • White LinkedIn Icon

Copyright ©2019 by Sanomics Limited. All rights reserved.


The name ‘Sanomics’ is derived from the word of Sanguis, the Latin word for blood, and genomics, which stands for the study of genes.

Since the launch of Sanomics, “Patient First” has always been our principle. Putting patients’ needs as our top priority, we strive to revolutionize current cancer treatments by providing safe and efficient liquid-based and tissue-based genomic tests to patients. We aim to provide easy and convenient access to our services and help doctors decide personalized cancer solutions for patients.


Began in Hong Kong, Sanomics continues our footsteps in South East Asia. Aspiring to develop and deploy the latest genetic and genomic technologies, we strive to work with health care professionals from hospitals, clinics, and drug companies to benefit patients in Hong Kong and the pan-Asian region. Being a pioneering company in providing genomic tests market in Hong Kong, we are committed to serving patients from all over the world.

Our milestones

Quick facts about us






Patient cases

Health care professionals


Countries and Region


Updated as of Aug 2019

Board of directors

Prof. Mok Tony Shu Kam

Dr. Zhou Daixing

Mr. Lee Kar Chung, Felix

Mr. Sy Ming Yiu, Stanley

Ms. Lo Pui Ying

Management Team

Laboratory Director

 Ms. Lo Pui Ying

Regional Sales & Marketing Manager

Mr. Cheung Yiu Wai, Gordon 


Mr. Sy Ming Yiu, Stanley

Corporate Manager

Ms. Wong Hoi Ting, Ann

Chief Financial Officer

Mr. Chan Wai Lung, Ricky

General Manager (Thailand)​

Mr. Zhong Jie Fu, Bobby


Regional Business Operations Manager

Business Operations Development

Ms. Chan Sze Ting, Christine

Mr. Lam Yik Chuen, Edward